Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2024-10-02

Clinical Trial Update: Impact of Body Weight and Weight Loss on Drug Bioavailability, Cardiovascular Risk Factors and Metabolic Biomarkers [NA]

View source ↗

Summary

This clinical trial update indicates an ongoing obesity study examining how body weight and weight loss affect drug bioavailability and metabolic/cardiovascular…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: The Hospital of Vestfold | Conditions: Obesity | NA | Status: ACTIVE_NOT_RECRUITING